Anticoagulants, primarily warfarin, are used to prevent thrombosis and thromboembolism in patients with atrial ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
June 22, 2012 — The the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee voted ...
June 22, 2012
June 11, 2012 — Boehringer Ingelheim Pharmaceuticals Inc. announced that the Pradaxa (dabigatran etexilate mesylate) ...
June 11, 2012
May 23, 2012 — Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system ...
May 23, 2012
Feature | Dave Fornell
May 17, 2012 — The U.S. Food and Drug Administration (FDA) today approved generic versions of the blood-thinning drug ...
May 17, 2012
May 15, 2012 — Reaching out to patients with a few simple phone calls significantly improves the likelihood they’ll ...
May 15, 2012
Feature | Dave Fornell
As an editor for DAIC and Imaging Technology News, I am a third-party observer in the cardiac and radiology markets. I ...
May 15, 2012
April 24, 2012—Providing more guidance to clinicians on the provision of optimal patient care, the American College of ...
April 24, 2012
April 19, 2012 — Spherix Inc. announced results from its recently completed studies using near-infrared spectroscopy on ...
April 19, 2012April 6, 2012 — The U.S. anticoagulant market is on the verge of a major shift in clinical practice, transitioning from ...
April 06, 2012
April 2, 2012 — It seems a picture is worth more than a thousand words for people who see evidence of coronary artery ...
April 02, 2012March 29, 2012 — Internet-based telemedicine systems appear to lead to more appropriate and effective pharmacotherapy ...
March 29, 2012
March 29, 2012 — Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly ...
March 29, 2012
March 29, 2012 — A three-pronged intervention in Brazilian public hospitals significantly improved physician adherence ...
March 29, 2012
March 27, 2012 – Researchers found the antiplatelet drug abciximab significantly decreased damage to the heart muscle in ...
March 27, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now